ARCA Biopharma Announces Solution for COVID-19 Related Blood Clotting  

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • 06/01/2020 at 5:45 pm #5367
    Colorado BioScience AssocationColorado BioScience Association
    Keymaster

    The company announced a new development program to evaluate AB201, a potent, selective inhibitor of tissue factor, as a potential treatment for COVID-19 associated coagulopathy and the related inflammatory response.

    More Information

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.